Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up. Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders Year: 2020
Impact of PAP in reducing cardiovascular events in OSA patients: a 10-years follow-up Source: International Congress 2019 – Current perspectives in obstructive sleep apnoea therapeutic plans and their effects Year: 2019
OSA and cardiovascular risk in women Source: 5th Sleep and Breathing Conference Year: 2019
Obstructive sleep apnea and risk of systemic hypertension among the middle-aged general population women from 30 to 70 years old. A follow-up study Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005
CPAP and measures of cardiovascular risks in patients with OSAS Source: Eur Respir J 2009; 33: 1520 Year: 2009
Obstructive sleep apnea is a risk factor for death in stroke patients – a 10-year follow-up Source: Eur Respir J 2007; 30: Suppl. 51, 328s Year: 2007
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006
Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study Source: Annual Congress 2005 - What should we know about our SAS patients Year: 2005
ERS Statement: Obstructive sleep-disordered breathing in children 2-18 years old. Risk factors, associated morbidity, predictors of persistent disease and assessment of disease severity Source: International Congress 2015 – Obstructive sleep apnoea in adults and children Year: 2015
Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007
Cardiovascular, metabolic prognosis and mortality of the positional sleep apnea syndrome: An historical cohort study including 240 patients Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Obstructive sleep apnoea and risk of cardiovascular disease in men. A follow-up study Source: Eur Respir J 2003; 22: Suppl. 45, 22s Year: 2003
Mortality in sleep apnoea syndrome: a review of the evidence Source: Eur Respir Rev 2007; 16: 203-210 Year: 2007
Prevalence of residual sleep apnea in patients treated with APAP and its predictive factors Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Asthma predictive factors in infants with bronchiolitis: asthma risk at 13-20 years of age Source: Eur Respir J 2010; 36: 221-222 Year: 2010
Obstructive sleep apnoea is not a risk factor for incident hospitalised depression: a historical cohort study Source: Eur Respir J, 49 (6) 1601361; 10.1183/13993003.01361-2016 Year: 2017
Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010